Lissoni P, Malugani F, Malysheva O, Kozlov V, Laudon M, Conti A, Maestroni G.
Clinical Trial 2002; 23(4): 341-344 PubMed PMID: 12195238 Keywords: Adjuvants, Immunologic:administration & dosage, Aged, Antineoplastic Agents:administration & dosage, Carcinoma, Neuroendocrine:drug therapy, Carcinoma, Renal Cell:drug therapy, Digestive System Neoplasms:drug therapy, Female, Humans, Injections, Subcutane. CitationOBJECTIVES: The preliminary applications of the psychoneuroimmunological knowledges to the treatment of human diseases have confirmed the .....
Lissoni P, Malugani F, Malysheva O, Kozlov V, Laudon M, Conti A, Maestroni G. Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system. Neuro Endocrinol Lett. 2002 Aug; 23(4): 341-344
Lissoni P, Malugani F, Bordin V, Conti A, Maestroni G, Tancini G.
Clinical Trial 2002; 23(3): 255-258 PubMed PMID: 12080288 Keywords: Aged, Antineoplastic Agents:administration & dosage, Carcinoma, Renal Cell:drug therapy, Drug Therapy, Combination, Female, Humans, Injections, Subcutaneous, Interleukin-2:administration & dosage, Kidney Neoplasms:drug therapy, Lymphocyte Count, Male, Mid. CitationOBJECTIVES: Recent advances in knowledge of Psychoneuroimmunology have shown that several neuroactive substances, including neurohormones .....
Lissoni P, Malugani F, Bordin V, Conti A, Maestroni G, Tancini G. A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone. Neuro Endocrinol Lett. 2002 Jun; 23(3): 255-258
Lissoni P, Cangemi P, Pirato D, Roselli M, Rovelli F, Brivio F, Malugani F, Maestroni G, Conti A, Laudon M, Malysheva O, Giani L.
Journal Article 2001; 22(3): 175-180 PubMed PMID: 11449195 Keywords: Emotions, Humans, Immune Tolerance, Neoplasms:immunology, Neuroimmunomodulation, Pineal Gland:physiology, Sexuality,. Citation: With the advances in the knowledge of neuroimmunomodulation, a new era of investigations about the chemical basis of the state of mind h.....
Lissoni P, Cangemi P, Pirato D, Roselli M, Rovelli F, Brivio F, Malugani F, Maestroni G, Conti A, Laudon M, Malysheva O, Giani L. A review on cancer--psychospiritual status interactions. Neuro Endocrinol Lett. 2001 Jun; 22(3): 175-180
Viganò D, Lissoni P, Rovelli F, Roselli M, Malugani F, Gavazzeni C, Conti A, Maestroni G.
Journal Article 2001; 22(2): 137-141 PubMed PMID: 11335890 Keywords: Adult, Circadian Rhythm, Female, Humans, Hydrocortisone:secretion, Male, Melatonin:secretion, Pineal Gland:secretion, Prolactin:secretion, Reference Values, Schizophrenia:physiopathology,. CitationOBJECTIVES: Recent studies have suggested the involvement of the pineal gland and its main hormone melatonin (MLT) in the pathogenesis of .....
Viganò D, Lissoni P, Rovelli F, Roselli M, Malugani F, Gavazzeni C, Conti A, Maestroni G. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia. Neuro Endocrinol Lett. 2001 Apr; 22(2): 137-141
Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni G.
Clinical Trial 2001; 22(1): 45-47 PubMed PMID: 11335879 Keywords: Adult, Aged, Bone Neoplasms:secondary, Carcinoma:blood, Carcinoma, Hepatocellular:blood, Carcinoma, Non-Small-Cell Lung:blood, Carcinoma, Renal Cell:blood, Colorectal Neoplasms:blood, Disease Progression, Endothelial Growth Factors:blood, Female, Humans, . CitationOBJECTIVES: The anticancer activity of the indole melatonin has been explained to be due to its immunomodulatory, anti-prolferative and an.....
Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni G. Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol Lett. 2001 Jan; 22(1): 45-47
Lissoni P, Vaghi M, Ardizzoia A, Fumagalli E, Tancini G, Gardani G, Conti A, Maestroni G.
Clinical Trial 2001; 22(1): 27-29 PubMed PMID: 11335876 Keywords: Adult, Aged, Antineoplastic Agents, Phytogenic:administration & dosage, Antineoplastic Combined Chemotherapy Protocols:administration & dosage, Biomarkers, Tumor:blood, Bone Neoplasms:secondary, Breast Neoplasms:blood, Disease Progression, Female, Humans,. CitationOBJECTIVES: Recent data have suggested that the efficacy of cancer chemotherapy does not depend only on tumor-related characteristics, but.....
Lissoni P, Vaghi M, Ardizzoia A, Fumagalli E, Tancini G, Gardani G, Conti A, Maestroni G. Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer. Neuro Endocrinol Lett. 2001 Jan; 22(1): 27-29